Your browser doesn't support javascript.
loading
IgE autoantibodies in serum and skin of non-bullous and bullous pemphigoid patients.
Lamberts, A; Kotnik, N; Diercks, G F H; Meijer, J M; Di Zenzo, G; Pas, H H; Jonkman, M F; Gibbs, B F; Raap, U; Horváth, B.
Afiliação
  • Lamberts A; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Kotnik N; Department of Experimental Dermatology and Allergology, University of Oldenburg, Oldenburg, Germany.
  • Diercks GFH; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Meijer JM; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Di Zenzo G; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Pas HH; Molecular and Cell Biology Laboratory, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
  • Jonkman MF; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Gibbs BF; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Raap U; Department of Experimental Dermatology and Allergology, University of Oldenburg, Oldenburg, Germany.
  • Horváth B; Department of Experimental Dermatology and Allergology, University of Oldenburg, Oldenburg, Germany.
J Eur Acad Dermatol Venereol ; 35(4): 973-980, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33058320
ABSTRACT

BACKGROUND:

Non-bullous pemphigoid (NBP) is a pemphigoid variant which frequently resembles other pruritic skin diseases. In contrast with bullous pemphigoid (BP), blisters are absent. In BP, previous studies showed that IgE autoantibodies may be involved in its pathogenesis. IgE-activated mast cells, basophils and eosinophils may participate in BP by inducing pruritus and possibly blister formation, although the differential role of IgE in NBP compared with BP has not yet been described.

OBJECTIVE:

To assess IgE in serum and skin of NBP and BP patients.

METHODS:

We examined total IgE and pemphigoid-specific IgE in the serum of 68 NBP and 50 BP patients by enzyme-linked immunosorbent assay (ELISA). Sera of 25 pemphigus patients and 25 elderly patients with pruritus were included as controls. Skin biopsies of 14 NBP and 14 BP patients with the highest IgE titres to NC16A were stained for IgE by immunofluorescence techniques.

RESULTS:

Total IgE was elevated in 63% of NBP and 60% of BP patients, and in 20% of pemphigus controls, as well as 60% of elderly controls. IgE ELISAs were more frequently positive in BP than in NBP (NC16A 18% vs. 9%, P = 0.139; BP230 34% vs. 22%, P = 0.149). IgE ELISAs for NC16A and BP230 were positive in 8% and 20% of elderly controls, respectively, while all pemphigus controls were negative. Two of 28 biopsies (7%; one NBP, one BP) showed linear IgE along the basement membrane zone, while in most biopsies (71% NBP; 86% BP) IgE was bound to dermal cells.

CONCLUSION:

Since IgE was present in the serum and skin of both NBP and BP patients, this supports IgE-dependent mechanisms common to both diseases, such as pruritus. However, it remains to be elucidated whether IgE contributes to blister formation in BP.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso Idioma: En Ano de publicação: 2021 Tipo de documento: Article